A-21
NDC 58264-0313, ALTERNARIA ALTERNATA, ASPERGILLUS NIGER VAR. NIGER, COCHLIOBOLUS SPICIFER, GIBBERELLA FUJIKUROI, COCHLIOBOLUS SATIVUS, CLADOSPORIUM BRUHNEI, MUCOR PLUMBEUS, PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM, AUREOBASIDIUM PULLULANS VAR. PULLUTANS, and RHIZOPUS STOLONIFER, solution, from DNA Labs, Inc..
- Product NDC
- 58264-0313
- Status
- Listed
- Labeler
- DNA Labs, Inc.
- Dosage form
- SOLUTION
- Route
- SUBLINGUAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/58264-0313 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ALTERNARIA ALTERNATA30 [hp_X]/mL
- ASPERGILLUS NIGER VAR. NIGER30 [hp_X]/mL
- COCHLIOBOLUS SPICIFER30 [hp_X]/mL
- GIBBERELLA FUJIKUROI30 [hp_X]/mL
- COCHLIOBOLUS SATIVUS30 [hp_X]/mL
- CLADOSPORIUM BRUHNEI30 [hp_X]/mL
- MUCOR PLUMBEUS30 [hp_X]/mL
- PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM30 [hp_X]/mL
- AUREOBASIDIUM PULLULANS VAR. PULLUTANS30 [hp_X]/mL
- RHIZOPUS STOLONIFER30 [hp_X]/mL
Pharmacologic classes
Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 58264-0313-1 | 58264031301 | 29.57 mL in 1 BOTTLE, GLASS (58264-0313-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 58264-0313 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/58264-0313 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 58264-0313. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.